Search - Archive ouverte HAL Access content directly

Filter your results

20 Results
authFullName_s : Vincent Ribrag
Image document

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma

Khalil Saleh , Morgane Cheminant , David Chiron , Barbara Burroni , Vincent Ribrag et al.
Cancers, 2022, 14 (13), pp.3229. ⟨10.3390/cancers14133229⟩
Journal articles hal-03745694v1
Image document

Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study

Alexandra-Cristina Paunescu , Christiane Bergman Copie , Sandra Malak , Steven Le Gouill , Vincent Ribrag et al.
Annals of Hematology, 2022, 101 (2), pp.317-332. ⟨10.1007/s00277-021-04689-4⟩
Journal articles inserm-03546781v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1
Image document

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Marie-Helene Delfau-Larue , Marie-Laure Boulland , Asma Beldi-Ferchiou , Pierre Feugier , Hervé Maisonneuve et al.
Blood Advances, 2020, 4 (14), pp.3217-3223. ⟨10.1182/bloodadvances.2020001955⟩
Journal articles inserm-03498367v1

A Recurrent Activating Missense Mutation in Waldenstrom Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation

Damien Roos-Weil , Camille Decaudin , Marine Armand , Veronique Della-Valle , Mboyba K. Diop et al.
Cancer Discovery, 2019, 9 (6), pp.796--811. ⟨10.1158/2159-8290.CD-18-0873⟩
Journal articles hal-02173764v1
Image document

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag , Serge Koscielny , Jacques Bosq , Thibaut Leguay , Olivier Casasnovas et al.
The Lancet, 2016, 387 (10036), pp.2402 - 2411. ⟨10.1016/S0140-6736(15)01317-3⟩
Journal articles inserm-01419476v1
Image document

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Christiane Pott , Eva Hoster , Marie-Hélène Delfau-Larue , Kheira Beldjord , Sebastian Böttcher et al.
Blood, 2010, 115 (16), pp.3215-23. ⟨10.1182/blood-2009-06-230250⟩
Journal articles inserm-00481726v1

CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner

Hadjer Abdelouahab , Yanyan Zhang , Monika Wittner , Shinya Oishi , Nobutaka Fujii et al.
Oncotarget, 2017, 8 (33), ⟨10.18632/oncotarget.10789⟩
Journal articles hal-02380531v1
Image document

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

Franck Morschhauser , Nathan H Fowler , Pierre Feugier , Reda Bouabdallah , Hervé Tilly et al.
New England Journal of Medicine, 2018, 379 (10), pp.934 - 947. ⟨10.1056/nejmoa1805104⟩
Journal articles inserm-01934589v1

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Marie-Hélène Delfau-Larue , Wolfram Klapper , Françoise Berger , Fabrice Jardin , Josette Brière et al.
Blood, 2015, 126 (5), pp.604-611. ⟨10.1182/blood-2015-02-628792⟩
Journal articles hal-02331700v1
Image document

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

Maxime Jullien , Benoit Tessoulin , Hervé Ghesquières , Lucie Oberic , Franck Morschhauser et al.
Cancers, 2021, 13 (18), pp.4503. ⟨10.3390/cancers13184503⟩
Journal articles inserm-03540506v1

Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.

Delphine Rolland , Vincent Ribrag , Corinne Haioun , Herve Ghesquieres , Fabrice Jardin et al.
Cancer Chemotherapy and Pharmacology, 2010, 65 (4), pp.781-90. ⟨10.1007/s00280-009-1185-4⟩
Journal articles istex inserm-00527708v1
Image document

(18)F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor.

Laurent Dercle , Romain-David Seban , Julien Lazarovici , Lawrence Schwartz , Roch Houot et al.
Journal of Nuclear Medicine, 2018, 59 (1), pp.15-24. ⟨10.2967/jnumed.117.193011⟩
Journal articles hal-01567811v1
Image document

Burkitt and Burkitt-Like Lymphomas: a Systematic Review

Khalil Saleh , Jean-Marie Michot , Valerie Camara-Clayette , Yegor Vassetzky , Vincent Ribrag et al.
Current Oncology Reports, 2020, 22 (4), ⟨10.1007/s11912-020-0898-8⟩
Journal articles hal-02870192v1

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

Camille Bigenwald , Yacine Haddad , Cassandra Thelemaque , Agathe Carrier , Roxanne Birebent et al.
OncoImmunology, 2023, 12 (1), ⟨10.1080/2162402X.2022.2163785⟩
Journal articles hal-03991815v1
Image document

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Benoit Tessoulin , David Chiron , Catherine Thieblemont , Lucie Oberic , Kamal Bouadballah et al.
Bone Marrow Transplantation, 2021, 56 (7), pp.1700-1709. ⟨10.1038/s41409-020-01198-2⟩
Journal articles hal-03203334v1

Large-scale nuclear remodeling and transcriptional deregulation occur on both derivative chromosomes after Mantle Cell Lymphoma chromosomal translocation

Anna Shmakova , Diego Germini , Yegor Vassetzky , Fatimata Bintou Sall , Andrei Pichugin et al.
Preprints, Working Papers, ... hal-02988682v1

Economic Burden in Non-Hodgkin Lymphoma Survivors: The French Lymphoma Study Association SIMONAL Cross-Sectional Study

Virginie Nerich , Christophe Guyeux , Michel Henry-Amar , Raphael Couturier , Catherine Thieblemont et al.
Cancer, 2022, 128 (3), pp.519 - 528
Journal articles hal-03692839v1
Image document

Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA

Steven Le Gouill , Hervé Ghesquieres , Lucie Obéric , Franck Morschhauser , Herve Tilly et al.
Blood, 2021, 137 (17), pp.2307-2320. ⟨10.1182/blood.2020008750⟩
Journal articles hal-03122586v1
Image document

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

Steven Le Gouill , Asma Beldi-Ferchiou , Marion Alcantara , Victoria Cacheux , Violaine Safar et al.
Lancet Haematology, 2020, 7 (11), pp.e798-e807. ⟨10.1016/S2352-3026(20)30291-X⟩
Journal articles hal-03012903v1